Simon is a Founding Partner at Stanley Capital. Since founding SC, Simon has originated and led the Noden Pharma and Essential deals. Prior to this, Simon gained lead investor experience as managing director and investment committee member at Ardian and director at Hg Capital.

At Ardian and Hg Capital Simon led or co-led deals into Parts Alliance, GSF, DDS Software, Zenith, Leasedrive, Trigo and Envision Pharma.Simon was named as one of the top 40 under 40 private equity practitioners in the inaugural Financial News awards in 2013. Simon’s pre-investing background was as an investment banker at Deutsche Bank and Citigroup, and a technology and healthcare management consultant at Arthur D Little.

Simon was a British Olympian in the Athens Olympic Games in 2004 (Rowing) and holds an MBA (INSEAD) and an MA (Oxford) where he was a Richard Blackwell Scholar and multiple College Prize winner in 1997 and 1998. Before university Simon held an IBM Scholarship in Computer Science where he helped program early voice recognition software.

James is a Founding Partner at Stanley Capital and co-led Stanley’s investment into Noden Pharma

Until September 2021 he was on the leadership team of Shell’s R&ES division, responsible for strategy and investment decision making for platforms across power, e-mobility, hydrogen, carbon offsets and venture investing

From 2016 to 2020, James co-led the rapid growth of Lightsource BP to become a global leader in the renewable energy sector. In that same period, James founded, raised and worked as managing partner of one of the world’s largest emerging market-focused green private equity funds, Eversource Capital, and completed investments across utility scale and distributed energy, mobility, water and waste management sectors.

Prior to joining Lightsource BP, James was co-head of EMEA Energy and UK & Ireland for Goldman Sachs’s Merchant Banking Division, its principal investment platform. Prior to GS, James worked at First Reserve and Advent International.

James holds a Masters and BA degree in Physics from Merton College, University of Oxford.

Patrick is a Founding Partner at Stanley Capital. He co-led Stanley’s investment into Noden. Patrick is a private equity and special situations investor with a strong track record across both equity and debt transactions.

Prior to Stanley Capital, Patrick was an investor at Centerbridge Partners and Monarch Alternative Capital. He began his career as an investment banker at JP Morgan.

Patrick holds a Masters in Mathematics from the Technical University Munich with summa cum laude. He is the author of the mathematical specialist book “A Fractional Heath-Jarrow-Morton Approach for Interest Rate Markets“, published while on a post-graduate research scholarship at Imperial College London.

David acts as Executive Chairman of S-Labs, previously serving as CEO of Emergence. David also sits on the Executive Committee of SCP. David has over 20 years of experience managing BPO and managed services firms during previous roles at Sutherland Global Services, Serco, Capgemini and PWC.

His career has focused on helping large corporations grow via digitally enabled process management and virtualisation of work. Prior to Emergence, Poole co-founded and was CEO of Symphony Ventures (2014-2019), a BPO and RPA-focused digital transformation consultancy, which was sold to Sykes Enterprises in 2018. Poole completed an MBA from Imperial College London and has a degree in Finance & Accounting from Leeds Metropolitan University.

Yair Erez joined in 2022 as head of research and partner at Stanley Capital Partners.

Prior to SCP, Yair was a senior private equity partner at Bain & Co for three years, where he focused on healthcare and life Sciences transactions. Before this he spent nine years as a partner at McKinsey and Co where he was part of the private equity practice focusing on healthcare and life sciences transactions as well as undertaking growth strategy work for specialty pharma and other life sciences organisations.

Yair has worked or invested with the SCP team on the three most recent investments Envision, Essential, and Noden Pharma.

Yair is a medical doctor specialising in gynaecology and gained his MD at Hebrew University where he was on the Dean’s list of honours, and an executive MBA at the Herzelliya Interdisciplinary Center.

Matt is a Partner at Stanley Capital and Chief Financial Officer (CFO). He has over 20 years of private equity experience mainly in CFO and chief operating officer (COO) positions.​

Prior to joining Stanley, Matt was CFO of Candover Investments plc and co-founder and COO of Arle Capital​. He co-led the buyout of Arle from Candover in a public market transaction, eventually selling Arle in 2017. Most recently Matt acted as interim CFO of Appian Capital​.

Matt is a qualified chartered accountant, having worked for KPMG in London and Brunei​. He holds an MA in Economic Development and Policy Analysis from Nottingham University.

Simon is a Founding Partner at Stanley Capital. Since founding SC, Simon has originated and led the Noden Pharma and Essential deals. Prior to this, Simon gained lead investor experience as managing director and investment committee member at Ardian and director at Hg Capital.

At Ardian and Hg Capital Simon led or co-led deals into Parts Alliance, GSF, DDS Software, Zenith, Leasedrive, Trigo and Envision Pharma.Simon was named as one of the top 40 under 40 private equity practitioners in the inaugural Financial News awards in 2013. Simon’s pre-investing background was as an investment banker at Deutsche Bank and Citigroup, and a technology and healthcare management consultant at Arthur D Little.

Simon was a British Olympian in the Athens Olympic Games in 2004 (Rowing) and holds an MBA (INSEAD) and an MA (Oxford) where he was a Richard Blackwell Scholar and multiple College Prize winner in 1997 and 1998. Before university Simon held an IBM Scholarship in Computer Science where he helped program early voice recognition software.

James is a Founding Partner at Stanley Capital and co-led Stanley’s investment into Noden Pharma

Until September 2021 he was on the leadership team of Shell’s R&ES division, responsible for strategy and investment decision making for platforms across power, e-mobility, hydrogen, carbon offsets and venture investing

From 2016 to 2020, James co-led the rapid growth of Lightsource BP to become a global leader in the renewable energy sector. In that same period, James founded, raised and worked as managing partner of one of the world’s largest emerging market-focused green private equity funds, Eversource Capital, and completed investments across utility scale and distributed energy, mobility, water and waste management sectors.

Prior to joining Lightsource BP, James was co-head of EMEA Energy and UK & Ireland for Goldman Sachs’s Merchant Banking Division, its principal investment platform. Prior to GS, James worked at First Reserve and Advent International.

James holds a Masters and BA degree in Physics from Merton College, University of Oxford.

Patrick is a Founding Partner at Stanley Capital. He co-led Stanley’s investment into Noden. Patrick is a private equity and special situations investor with a strong track record across both equity and debt transactions.

Prior to Stanley Capital, Patrick was an investor at Centerbridge Partners and Monarch Alternative Capital. He began his career as an investment banker at JP Morgan.

Patrick holds a Masters in Mathematics from the Technical University Munich with summa cum laude. He is the author of the mathematical specialist book “A Fractional Heath-Jarrow-Morton Approach for Interest Rate Markets“, published while on a post-graduate research scholarship at Imperial College London.

Arianna is part of the investment team at Stanley Capital.

Arianna began her career at Goldman Sachs and spent over six years in the consumer, retail and healthcare M&A team, working across a set of large transactions spanning acquisitions, mergers and equity capital raises.

Arianna holds a Bachelor in Economics, Management and Finance from Bocconi University and a MSc in Financial Economics from Oxford University.

Rodolphe is an Associate with the Investment Team.

Rodolphe joined SCP from Morgan Stanley where he focused on healthcare transactions from its London office. Prior to that, Rodolphe began his career at Citi and spent four years in the healthcare investment banking team working across acquisitions, capital raises, and joint ventures.

Rodolphe and holds a MSc in Financial Markets and Investments from SKEMA Business School.

Yair Erez joined in 2022 as head of research and partner at Stanley Capital Partners.

Prior to SCP, Yair was a senior private equity partner at Bain & Co for three years, where he focused on healthcare and life Sciences transactions. Before this he spent nine years as a partner at McKinsey and Co where he was part of the private equity practice focusing on healthcare and life sciences transactions as well as undertaking growth strategy work for specialty pharma and other life sciences organisations.

Yair has worked or invested with the SCP team on the three most recent investments Envision, Essential, and Noden Pharma.

Yair is a medical doctor specialising in gynaecology and gained his MD at Hebrew University where he was on the Dean’s list of honours, and an executive MBA at the Herzelliya Interdisciplinary Center.

Marnelia is an Associate with the Investment Strategy Team at Stanley Capital.

Prior to joining Stanley, Marnelia spent five years as a consultant at OC&C Strategy. There she advised private equity and corporate clients on M&A and strategy projects across B2B Services and Tech sectors.

Marnelia holds a MSc in Business Analytics from Imperial College London and BEng from Stellenbosch University.

David acts as Executive Chairman of S-Labs, previously serving as CEO of Emergence. David also sits on the Executive Committee of SCP. David has over 20 years of experience managing BPO and managed services firms during previous roles at Sutherland Global Services, Serco, Capgemini and PWC.

His career has focused on helping large corporations grow via digitally enabled process management and virtualisation of work. Prior to Emergence, Poole co-founded and was CEO of Symphony Ventures (2014-2019), a BPO and RPA-focused digital transformation consultancy, which was sold to Sykes Enterprises in 2018. Poole completed an MBA from Imperial College London and has a degree in Finance & Accounting from Leeds Metropolitan University.

Felix serves as CEO of S-Labs, having previously been CEO of Symphony Lam in the US and Latin America since March 2018.

Felix is considered an industry veteran with over 20 years experience in BPO and supply chain planning consulting and technology In particular, where Felix has a proven track record in developing Latin American business and operations for multinational consultancies Sutherland Global Services, Capgemini and Arthur Andersen.

Felix joined Symphony Ventures in June 2017 to establish the firm’s regional operations. Felix obtained an MBA from the University of Pittsburgh, Katz Graduate School of Business and a degree in Engineering & Industrial Business Management from the Universidad Católica Argentina.

• Ex CEO Thyssen Krupp Industrial Services
• Ex CEO Siemens Compression and Solutions

Matt is a Partner at Stanley Capital and Chief Financial Officer (CFO). He has over 20 years of private equity experience mainly in CFO and chief operating officer (COO) positions.​

Prior to joining Stanley, Matt was CFO of Candover Investments plc and co-founder and COO of Arle Capital​. He co-led the buyout of Arle from Candover in a public market transaction, eventually selling Arle in 2017. Most recently Matt acted as interim CFO of Appian Capital​.

Matt is a qualified chartered accountant, having worked for KPMG in London and Brunei​. He holds an MA in Economic Development and Policy Analysis from Nottingham University.

Natalie is the Executive Assistant for the Founding Partners at Stanley Capital and acts as Office Manager

Prior to joining Stanley Capital, Natalie was an Executive Assistant at Lightsource BP for 7 years

Natalie has spent over 20 years living abroad in the Middle East and Southern Africa working across a variety of industries including Media, Asset Management and Conferencing

Marissa is the Executive Assistant for Founding Partners, Simon and Patrick, at Stanley Capital.

Prior to joining Stanley Capital, Marissa was an Executive Assistant at Arab Banking Corporation.

Marissa has worked across a variety of industries including Interior Design, Finance and Fashion, where she spent 5 years at global brand Burberry.